Table 1. Characteristics of PD Products.

Patient	SCT CD34/kg (106)	SCT CD3/kg (102)	SD CD3/kg (106)	Viability after processing (%)	Viability after thaw (%)	CD4/CD8 ratio prior to PD	CD4/CD8 ratio after PD
1	6.0	6.2	5.0	93	48	1.63	0.56
2	7.9	8.1	5.0	87	81	0.94	0.77
3	6.0	25.7	5.0	93	58	No Sample	0.93
4	5.4	11.3	5.0	89	73	0.78	0.74
5	9.5	0	5.0	96	53	0.89	0.57
6	6.0	0	5.0	87	59	1.68	1.15
7	4.9	5.2	5.0	86	61	1.40	0.29
8	7.3	24.8	5.0	92	71	3.13	2.11
9	6.7	20.3	5.0	90	76	2.06	No Sample
10	7.3	70.0	5.0	92	82	3.11	2.23
11	4.4	9.1	5.0	87	67	1.57	2.32
12	3.9	19.4	5.0	73	51	2.77	No Sample
13	3.1	10.9	5.0	93	48	3.60	1.51
14	9.6	29.0	5.0	70	75	1.13	1.37
15	6.3	0	5.0	92	52	1.78	2.05
16	6.9	59.6	5.0	91	73	1.01	0.68
17	7.9	16.2	5.0	93	77	3.97	0.79
18	4.7	9.6	5.0	87	65	0.91	0.56
19	3.6	16.3	5.0	84	65	2.21	2.57
20	7.3	7.5	5.0	75	47	1.02	0.94
21	6.8	27.7	5.0	85	50	2.06	0.79
22	7.6	7.7	5.0	95	83	2.03	0.76
23	6.9	21.2	5.0	90	73	2.47	0.73
24	5.0	10.0	5.0	96	75	1.35	1.16
Median	6.5	11.1	5.0	90	66	1.67	0.56